GSK's Asthma Drug Meets Main Goal In Phase 3 Study In Patients With Smoker's Lungs, Prepares Competition With Amgen/AstraZeneca's Drug

Benzinga29minutes ago

Vor Bio Stock Rallies Post-market on Trem-cel Study Data

Seeking Alpha04:58

Eli Lilly Bets $409M for AI-focused Drug Discovery

Seeking Alpha02:41

Perspective Gets FDA Fast Track Status for Radiopharmaceutical VMT101

Seeking Alpha01:16

Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration

Benzinga00:53

Battle Over Compounded Weight-Loss Medications - Sustainability and Regulation

Benzinga00:47